Related Experiment Video
Updated: Jun 25, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Camouflage and misdirection: the full-on assault of ebola virus disease
John Misasi1, Nancy J Sullivan2
1Boston Children's Hospital, Department of Medicine, Division of Infectious Diseases, Boston, MA 02115, USA.
Abstract:
Ebolaviruses cause a severe hemorrhagic fever syndrome that is rapidly fatal to humans and nonhuman primates. Ebola protein interactions with host cellular proteins disrupt type I and type II interferon responses, RNAi antiviral responses, antigen presentation, T-cell-dependent B cell responses, humoral antibodies, and cell-mediated immunity. This multifaceted approach to evasion and suppression of innate and adaptive immune responses in their target hosts leads to the severe immune dysregulation and "cytokine storm" that is characteristic of fatal ebolavirus infection. Here, we highlight some of the processes by which Ebola interacts with its mammalian hosts to evade antiviral defenses.
Related Concept Videos
Cross-reactivity
Yellow Fever
Malaria
Inhibitors Of Virion Release

